A nonsense mutation in PRNP associated with clinical Alzheimer's disease

Neurobiology of Aging

Volumn 35, Issue 11, 2014, Pages 2656.e13-2656.e16

  Guerreiro, Rita ^a   Brás, José ^a   Wojtas, Aleksandra ^b   Rademakers, Rosa ^b   Hardy, John ^a   Graff Radford, Neill ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Exome sequencing; Nonsense mutation; Prion; PRNP

Indexed keywords

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; EXOME; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MALE; MENTAL DETERIORATION; NONSENSE MUTATION; PRNP GENE; COGNITIVE DEFECT; GENETIC ASSOCIATION STUDY; GENETICS; GENOTYPE; HOMOZYGOTE; MEMORY DISORDER; PHENOTYPE; PRION; SEQUENCE ANALYSIS; STOP CODON;

PRION; PRNP PROTEIN, HUMAN; STOP CODON;

ALLELES; ALZHEIMER DISEASE; CODON, NONSENSE; COGNITION DISORDERS; EXOME; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; MEMORY DISORDERS; PHENOTYPE; PRIONS; SEQUENCE ANALYSIS;

EID: 84922916943     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.013     Document Type: Article

References (20)

1. Bras J., Guerreiro R., Hardy J. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat. Rev. Neurosci. 2012, 13:453-464.
2. Bras J., Verloes A., Schneider S.A., Mole S.E., Guerreiro R.J. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet. 2012, 21:2646-2650.
3. Cingolani P., Platts A., Wang le L., Coon M., Nguyen T., Wang L., Land S.J., Lu X., Ruden D.M. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012, 6:80-92.
4. Cruchaga C., Karch C.M., Jin S.C., Benitez B.A., Cai Y., Guerreiro R., Harari O., Norton J., Budde J., Bertelsen S., Jeng A.T., Cooper B., Skorupa T., Carrell D., Levitch D., Hsu S., Choi J., Ryten M., Hardy J., Trabzuni D., Weale M.E., Ramasamy A., Smith C., Sassi C., Bras J., Gibbs J.R., Hernandez D.G., Lupton M.K., Powell J., Forabosco P., Ridge P.G., Corcoran C.D., Tschanz J.T., Norton M.C., Munger R.G., Schmutz C., Leary M., Demirci F.Y., Bamne M.N., Wang X., Lopez O.L., Ganguli M., Medway C., Turton J., Lord J., Braae A., Barber I., Brown K., Passmore P., Craig D., Johnston J., McGuinness B., Todd S., Heun R., Kolsch H., Kehoe P.G., Hooper N.M., Vardy E.R., Mann D.M., Pickering-Brown S., Kalsheker N., Lowe J., Morgan K., David Smith A., Wilcock G., Warden D., Holmes C., Pastor P., Lorenzo-Betancor O., Brkanac Z., Scott E., Topol E., Rogaeva E., Singleton A.B., Kamboh M.I., St George-Hyslop P., Cairns N., Morris J.C., Kauwe J.S., Goate A.M. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 2014, 505:550-554.
5. Finckh U., Muller-Thomsen T., Mann U., Eggers C., Marksteiner J., Meins W., Binetti G., Alberici A., Sonderegger P., Hock C., Nitsch R.M., Gal A. High frequency of mutations in four different disease genes in early-onset dementia. Ann. N.Y Acad. Sci. 2000, 920:100-106.
6. Ghetti B., Piccardo P., Spillantini M.G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C., Frangione B., Bugiani O., Giaccone G., Prelli F., Goedert M., Dlouhy S.R., Tagliavini F. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc. Natl. Acad. Sci. U.S.A 1996, 93:744-748.
7. Guerreiro R., Bras J., Hardy J. SnapShot: genetics of Alzheimer's disease. Cell 2013, 155. 968-968e1.
8. Guerreiro R., Bras J., Hardy J., Singleton A. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations. Hum. Mol. Genet. 2014, [Epub ahead of print].
9. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. N. Eng. J. Med. 2013, 368:117-127.
10. Guerreiro R.J., Lohmann E., Bras J.M., Gibbs J.R., Rohrer J.D., Gurunlian N., Dursun B., Bilgic B., Hanagasi H., Gurvit H., Emre M., Singleton A., Hardy J. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 2013, 70:78-84.
11. Jansen C., Parchi P., Capellari S., Vermeij A.J., Corrado P., Baas F., Strammiello R., van Gool W.A., van Swieten J.C., Rozemuller A.J. Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol. 2010, 119:189-197.
12. Jayadev S., Nochlin D., Poorkaj P., Steinbart E.J., Mastrianni J.A., Montine T.J., Ghetti B., Schellenberg G.D., Bird T.D., Leverenz J.B. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann. Neurol. 2011, 69:712-720.
13. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., Rujescu D., Hampel H., Giegling I., Andreassen O.A., Engedal K., Ulstein I., Djurovic S., Ibrahim-Verbaas C., Hofman A., Ikram M.A., van Duijn C.M., Thorsteinsdottir U., Kong A., Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Eng. J. Med. 2013, 368:107-116.
14. Kitamoto T., Iizuka R., Tateishi J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 1993, 192:525-531.
15. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
16. Matsuzono K., Ikeda Y., Liu W., Kurata T., Deguchi S., Deguchi K., Abe K. A novel familial prion disease causing pan-autonomic-sensory neuropathy and cognitive impairment. Eur. J. Neurol. 2013, 20:e67-e69.
17. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., DePristo M.A. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20:1297-1303.
18. Mead S., Gandhi S., Beck J., Caine D., Gallujipali D., Carswell C., Hyare H., Joiner S., Ayling H., Lashley T., Linehan J.M., Al-Doujaily H., Sharps B., Revesz T., Sandberg M.K., Reilly M.M., Koltzenburg M., Forbes A., Rudge P., Brandner S., Warren J.D., Wadsworth J.D., Wood N.W., Holton J.L., Collinge J. A novel prion disease associated with diarrhea and autonomic neuropathy. N. Engl. J. Med. 2013, 369:1904-1914.
19. Revesz T., Holton J.L., Lashley T., Plant G., Frangione B., Rostagno A., Ghiso J. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol. 2009, 118:115-130.
20. Smith K.R., Damiano J., Franceschetti S., Carpenter S., Canafoglia L., Morbin M., Rossi G., Pareyson D., Mole S.E., Staropoli J.F., Sims K.B., Lewis J., Lin W.L., Dickson D.W., Dahl H.H., Bahlo M., Berkovic S.F. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 2012, 90:1102-1107.